Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Burnie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News21 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation